Zim Laboratories Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Anwar Daud, was filed 29 Jul 2026.
Zim Laboratories: what insiders have been doing
This page follows insider dealings at Zim Laboratories as filed with SEBI (PIT + SAST). The last twelve months, up to 8 November 2026, brought 2 filings signed by 2 insiders.
Not one open-market sale was filed. On the buying side, 2 insiders reported 2 purchases. No amount is published for 2 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 1 major shareholder.
Compared with its exchange (1,984 companies, median 4 filings), a count of 2 filings is below the norm. Looking back to 2026, when coverage begins, insiders filed 2 purchases and no sales.
The latest purchase dates back some time: it was published 102 days ago, on 29 July 2026.
Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- +21.8%Entry ₹120.65 · Close at T+90 ₹147.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 80,000 shares--SEBI:29d3a99cc819cac6cc96d981df0a03c15ab07df7Canonical exit: 27 Oct 2026 (T+90)
- 80,000 shares-NoneSEBI:874c110783e8aa7ba5aa5beee40487fd03b6f6d5Canonical exit: 12 Oct 2026 (T+90)
2 of 2 declarations
About Zim Laboratories
Zim Laboratories is a company focused on the research and development of pharmaceutical products. It is listed on the Bombay Stock Exchange under the symbol XBOM.